Evaluation of combination protocols of the chemotherapeutic agent FX-9 with azacitidine, dichloroacetic acid, doxorubicin or carboplatin on prostate carcinoma cell lines

por Weiner, Franziska, Schille, Jan Torben, Hein, Jens Ingo, Wu, Xiao-Feng, Beller, Matthias, Junghanß, Christian, Murua Escobar, Hugo, Nolte, Ingo
Publicado 2021

The effect of treatment with pimobendan in dogs with preclinical mitral valve disease – a placebo-controlled double-blinded crossover study

por Klein, Stephanie, Nolte, Ingo, Rumstedt, Katja, Sehn, Maximiliane, Raue, Jonathan Friedemann, Weiner, Franziska, Treese, Julia Sophie, Beyerbach, Martin, Bach, Jan-Peter
Publicado 2021

Isoquinolinamine FX-9 Exhibits Anti-Mitotic Activity in Human and Canine Prostate Carcinoma Cell Lines

por Schille, Jan Torben, Nolte, Ingo, Packeiser, Eva-Maria, Wiesner, Laura, Hein, Jens Ingo, Weiner, Franziska, Wu, Xiao-Feng, Beller, Matthias, Junghanss, Christian, Murua Escobar, Hugo
Publicado 2019